FDA Approves Eli Lilly's Foundayo as Second Oral GLP-1 Obesity Treatment
The FDA has approved Foundayo, a new oral obesity medication from Eli Lilly, making it the second GLP-1 therapy available as a pill after Wegovy, offering patients a convenient alternative to injectable treatments.
Key Points
- FDA approved Foundayo, developed by Eli Lilly, for obesity treatment
- Foundayo is only the second GLP-1 therapy approved as an oral pill (after Wegovy)
- Provides convenient oral alternative to injectable GLP-1 treatments
- Represents major milestone in expanding obesity treatment options
Full Details
The FDA has approved Foundayo, developed by pharmaceutical company Eli Lilly, as a new oral medication for obesity treatment. This approval marks a significant milestone in obesity care as Foundayo becomes only the second GLP-1 (glucagon-like peptide-1) therapy approved in pill form, following Wegovy. The oral formulation offers a convenient alternative to the standard injectable GLP-1 therapies that have proven effective for weight loss but require needles. This development represents a major shift in obesity treatment options, potentially increasing accessibility for patients who prefer oral medications over injections. The approval expands treatment choices for the millions of Americans struggling with obesity.
Why It Matters
The approval of oral GLP-1 medications could significantly expand access to effective obesity treatments, as many patients avoid injectable therapies. This may intensify competition in the weight loss medication market and potentially lower costs over time.
Get stories like this delivered daily
AI-curated news, personalized to your interests. Zero noise.
Start 7-Day Free Trial →More in Global News
Trump Fires Pam Bondi as Attorney General
President Trump has fired Attorney General Pam Bondi, marking a significant leadership change at the Department of Justice. The firing raises questions about Bondi's tenure and her legacy at the DOJ.
Geopolitical Anxiety Overtakes Economy as Top Barrier to International Travel
A new Travel Weekly survey reveals 72% of U.S. travel advisors report clients postponing or canceling international trips due to global conflicts, nearly doubling from 38% in December and surpassing concerns over inflation (55%) and the economy (42%).
White House Proposes Massive Defense Spending Increase, Lawmakers React
Lawmakers are responding to the White House's substantial defense spending proposal, with reactions ranging from support to criticism regarding the budget request.
Iran War's Economic Impact Felt Across US Economy with Signs of Further Strain Ahead
Americans are experiencing rising costs due to the Iran conflict, with gas prices exceeding $6/gallon in Los Angeles, Amazon adding fuel surcharges to deliveries, and mortgage rates hitting seven-month highs.